FSHD Society to enhance trial design with AI technology deployment
The FSHD Society is set to improve clinical trial design for facioscapulohumeral muscular dystrophy by deploying AI technology.
Source: clinicaltrialsarena.com
Stay updated with breaking news from Solve Barriers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FSHD Society is set to improve clinical trial design for facioscapulohumeral muscular dystrophy by deploying AI technology.
Randolph, Massachusetts (PRWEB) April 21, 2022 -- The FSHD Society announced that it is launching a collaboration involving the FSHD Clinical Trial Research